These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 79025)

  • 1. Increased dopamine-receptor sensitivity in schizophrenia.
    Owen F; Cross AJ; Crow TJ; Longden A; Poulter M; Riley GJ
    Lancet; 1978 Jul; 2(8083):223-6. PubMed ID: 79025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue.
    Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI
    Adv Biochem Psychopharmacol; 1980; 21():443-50. PubMed ID: 6246753
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased brain dopamine and dopamine receptors in schizophrenia.
    Mackay AV; Iversen LL; Rossor M; Spokes E; Bird E; Arregui A; Creese I; Synder SH
    Arch Gen Psychiatry; 1982 Sep; 39(9):991-7. PubMed ID: 7115016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.
    Lee T; Seeman P; Tourtellotte WW; Farley IJ; Hornykeiwicz O
    Nature; 1978 Aug; 274(5674):897-900. PubMed ID: 683328
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride.
    Seeman P; Niznik HB; Guan HC
    Arch Gen Psychiatry; 1990 Dec; 47(12):1170-2. PubMed ID: 2244801
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
    Seeman P
    Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
    Mjörndal T; Winblad B
    Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
    Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
    Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
    Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain.
    Klemm N; Murrin LC; Kuhar MJ
    Brain Res; 1979 Jun; 169(1):1-9. PubMed ID: 455088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptors in the Parkinsonian brain.
    Rinne UK; Lönnberg P; Koskinen V
    J Neural Transm; 1981; 51(1-2):97-106. PubMed ID: 6114985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
    Wong DF; Wagner HN; Tune LE; Dannals RF; Pearlson GD; Links JM; Tamminga CA; Broussolle EP; Ravert HT; Wilson AA; Toung JK; Malat J; Williams JA; O'Tuama LA; Snyder SH; Kuhar MJ; Gjedde A
    Science; 1986 Dec; 234(4783):1558-63. PubMed ID: 2878495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.
    Pearlson GD; Wong DF; Tune LE; Ross CA; Chase GA; Links JM; Dannals RF; Wilson AA; Ravert HT; Wagner HN
    Arch Gen Psychiatry; 1995 Jun; 52(6):471-7. PubMed ID: 7771917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.
    Nagy JI; Lee T; Seeman P; Fibiger HC
    Nature; 1978 Jul; 274(5668):278-81. PubMed ID: 683308
    [No Abstract]   [Full Text] [Related]  

  • 18. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
    Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA
    Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.
    Cross AJ; Crow TJ; Ferrier IN; Johnstone EC; McCreadie RM; Owen F; Owens DG; Poulter M
    J Neural Transm Suppl; 1983; 18():265-72. PubMed ID: 6135745
    [No Abstract]   [Full Text] [Related]  

  • 20. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.